Home » Topics » Disease categories and therapies » Gastrointestinal

Gastrointestinal
RSS

Korean investigators design effective and safe agents for HBV

July 10, 1998

New peristaltic stimulant on the way to market in Japan

July 9, 1998

New herbal remedy for liver diseases improves liver function and quality of life

July 8, 1998

Belgian scientists on the way to developing a therapeutic vaccine for HCV?

July 8, 1998

Novel flavonoid derivative SU-840 with potent gastroprotective and ulcer-healing effects

July 7, 1998

Anti-H. pylori compounds prepared at Fujisawa

July 3, 1998

First 10-day treatment for H. pylori infection approved by FDA

July 2, 1998

Centocor receives complete review letter for infliximab

July 2, 1998

Chugai begins clinical testing of prokinetic agent

July 2, 1998

FDA, Janssen advise of Propulsid warning label changes

July 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...